Modulation of toll-like signal path of allergic asthma by CpG-ODNs from Bordetella pertussis

Yaoxue Xuebao

Volumn 46, Issue 3, 2011, Pages 285-292

  Zhang, Bao Yuan ^a   Chi, Shen ^a   Sun, Yun ^a  

^a CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

Author keywords

Asthma; Bordetella pertussis; Oligodeoxynucleotides; Th1 Th2; Toll like receptor 9

Indexed keywords

BETA ACTIN; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; OVALBUMIN; TOLL LIKE RECEPTOR 9; VASCULOTROPIN;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; LEUKOCYTE; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ASTHMA; BORDETELLA PERTUSSIS; BRONCHOALVEOLAR LAVAGE FLUID; EOSINOPHILS; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-4; LEUKOCYTE COUNT; LEUKOCYTES; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; OLIGODEOXYRIBONUCLEOTIDES; OVALBUMIN; RANDOM ALLOCATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPLEEN; TH1-TH2 BALANCE; TOLL-LIKE RECEPTOR 9; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79953185041     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ye RG, Lu ZY. Immunology [M]. Beijing: People's Medical Publishing House, 2004: 63-74.
2. Yu JL, Dou DQ, Chen XH, et al. Ginsenoside-Ro enhances cell proliferation and modulates Th1/Th2 cytokines production in murine splenocytes [J]. Acta Pharm Sin, 2005, 40: 332-336.
3. Kim YS, Kwon KS, Kim DK, et al. Inhibition of murine allergic airway disease by Bordetella pertussis [J]. Immunology, 2004, 112: 624-630.
4. Qin DY, Huang R, Wu T. In vitro arsenic trioxide induces apoptosis in T cells of asthmatic patients by a Bcl-2 related mechanism [J]. Acta Pharm Sin, 2008, 43: 35-43.
5. Kline JN, Waldschmidt TJ, Businga TR, et al. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma [J]. J Immunol, 1998, 160: 2555-2559. (Pubitemid 28136702)
6. Kline JN. Immunotherapy of asthma using CpG oligodeoxynucleotides [J]. Immunol Res, 2007, 39: 279-286. (Pubitemid 47574894)
7. Liu HZ, Yang HZ, Mi S, et al. Toll like receptor 2 mediates bleomycin-induced acute lung injury, inflammation and fibrosis in mice [J]. Acta Pharm Sin, 2010, 45: 976-986.
8. Carbonetti NH. Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease [J]. Curr Opin Pharmacol, 2007, 7: 272-278. (Pubitemid 46731195)
9. Guiso N. Bordetella pertussis and pertussis vaccines [J]. Clin Infect Dis, 2009, 49: 1565-1569.
10. Barnard A, Mahon BP, Watkins J, et al. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or ThO [J]. Immunology, 1996, 87: 372-380.
11. Sun Y, Chi S, Zhang BY. Research on pharmacological mechanism of the treatment of asthma by oral Bacdetella pertussis [J]. J Pharm Sci, 2009, 109 (Suppl 1): 207.
12. Mills KH. Immunity to Bordetella pertussis [J]. Microbes Infect, 2001, 3: 655-677.
13. Ausiello CM, Lande R, Urbani F, et al. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine [J]. J Infect Dis, 2000, 181: 1989-1995. (Pubitemid 30416162)
14. Kitagaki K, Businga TR, Kline JN. Oral administration of CpG-ODNs suppresses antigen-induced asthma in mice [J]. Clin Exp Immunol, 2006, 143: 249-259.
15. Yasuda K, Kawano H, Yamane I, et al. Restricted cytokine production from mouse peritoneal macrophages in culture in spite of extensive uptake of plasmid DNA [J]. Immunology, 2004, 111: 282-290. (Pubitemid 38365750)
16. Du XG, Dong XW, Chen JQ, et al. Immunoregulatory effects of pertussis protein on allergic asthma in mouse [J]. J Zhejiang Univ (Med Sci), 2008, 4: 351-356.
17. Jain VV, Kitagaki K, Businga T, et al. CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma [J]. J Allergy Clin Immunol, 2002, 110: 867-872.
18. Broide D, Schwarze J, Tighe H, et al. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice [J]. J Immunol, 1998, 161: 7054-7062. (Pubitemid 28562256)
19. Amaral CC, Garcia IP, Fernandes GF, et al. Adjuvant effect of synthetic oligodeoxyribonucleotides (CpG-ODN) from the Paracoccidioides brasiliensis gp43 gene on the Th2-Th1 immunomodulation of experimental paracoccidioidomycosis [J]. Scand J Immunol, 2005, 62: 325-333. (Pubitemid 41565384)
20. Kline JN, Krieg AM. CpG oligodeoxynucleotides [J]. 2001, 31: 229-232.
21. Krieg AM, Yi A, Matson S. CpG motifs in bacterial DNA trigger direct B-cell activation [J]. Nature, 1995, 374: 546-549.
22. Hemmi H, Takeuchi O, Kawai T. A Toll-like receptor recognizes bacterial DNA [J]. Nature, 2000, 408: 740-745. (Pubitemid 32015992)
23. Vollmer J, Krieg AM. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists [J]. Adv Drug Deliv Rev, 2009, 61: 195-204.
24. Feistritzer C, Kaneider NC, Sturn DH, et al. Expression and function of the vascular endothelial growth factor receptor FLT-1 in human eosinophils [J]. Am J Respir Cell Mol Biol, 2004, 30: 729-735. (Pubitemid 38591225)
25. Fanucchi MV, Schelegle ES, Baker GL, et al. Immunostimulatory oligonucleotides attenuate airways remodeling in allergic monkeys [J]. Am J Respir Crit Care Med, 2004, 170: 1153-1157.
26. Hamid Q, Tulic M. Immunobiology of asthma [J]. Annu Rev Physiol, 2009, 71: 489-507.
27. Chi S, Sun Y. Research progress on mucosal tolerance in treatment of allergic diseases [J]. Med Recapit, 2008, 13: 1946-1949.
28. Busse WW, Lemanske RF Jr. Asthma [J]. N Engl J Med, 2001, 344: 350-362.